Source: http://uscode.house.gov/view.xhtml?req=(title:42%20section:284q%20edition:prelim)
Timestamp: 2019-01-18 13:59:53
Document Index: 205860391

Matched Legal Cases: ['§ 284', '§409', '§4305', '§7042', '§7042', '§7042']

[USC04] 42 USC 284q: Pain research
<< Previous TITLE 42 / CHAPTER 6A / SUBCHAPTER III / Part B / § 284q Next >>
42 USC 284q: Pain research Text contains those laws in effect on January 17, 2019
(B) identify critical gaps in basic and clinical research on-
(C) make recommendations to the Director of NIH-
(July 1, 1944, ch. 373, title IV, §409J, as added Pub. L. 111–148, title IV, §4305(b), Mar. 23, 2010, 124 Stat. 585 ; amended Pub. L. 115–271, title VII, §7042, Oct. 24, 2018, 132 Stat. 4016 .)
2018-Subsec. (b)(5)(A). Pub. L. 115–271, §7042(1)(A), substituted "treatment, and management of pain and diseases and disorders associated with pain, including information on best practices for the utilization of non-pharmacologic treatments, non-addictive medical products, and other drugs or devices approved or cleared by the Food and Drug Administration" for "and treatment of pain and diseases and disorders associated with pain".
Subsec. (b)(5)(B). Pub. L. 115–271, §7042(1)(B), substituted "on-" and cls. (i) to (iii) for "on the symptoms and causes of pain;".